More than half of Medicare beneficiaries are now enrolled in Medicare Advantage (MA), with the program seeing steady growth over the years. This growth has come despite the program becoming a focus of scrutiny from the federal government, leading to debates about its future and effectiveness.
Such matters of contention were brought to light during a recent panel at HLTH 2023 held in Las Vegas, where two experts presented differing views on the topic. Dr. Rick Gilfillan, an independent consultant and the former CEO of Trinity Health System, referred to the program as a “failed experiment,” due to significant subsidization and challenges with care access.
According to Gilfillan, who also served as the former director of the Center for Medicare and Medicaid Innovation (CMMI), the program’s cost exceeds that of traditional Medicare. He attributed part of the program’s failure to obstacles in care access that were put in place by MA plans.
However, Dr. Sachin Jain, CEO of MA insurer SCAN Health Plan, disagreed with Gilfillan’s critique. Jain called attention to the traditional fee-for-service Medicare, stating that it had not provided beneficiaries with a sense of stability and security due to growing healthcare costs.
While he acknowledged the need for reforms, Jain suggested that the perceived higher costs of MA could be due to the program offering more benefits that traditional Medicare doesn’t cover, such as dental, vision, and audiology coverage. Gilfillan, on the other hand, proposed a complete overhaul of both Medicare and MA, creating a level playing field by stopping overpayment and including robust coverage in the standard benefits package.
Jain concluded the debate by stating that while Medicare Advantage has its flaws, healthcare professionals should proactively strive to rectify them rather than waiting for legislative action.
Almost reflexively, this raises the crucial question – is Medicare Advantage a failed experiment or a program with substantial potential but needing adjustments? As enrollment continues to increase and scrutiny likewise, only time will effectively reveal the final verdict. Meanwhile, the full debate offers much food for thought for those proactive in navigating the complexities of the American health care landscape.